Evidence map›Paper›PMID 39852764›Full record

ArticleCancer discovery2025

Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells.

Ilana Struys, Carolina Velázquez, Joske Ubels, Charlotte L LeJeune, Markus J van Roosmalen, Axel K M Rosendahl Huber, Anais J C N van Leeuwen, Wouter Bossuyt, Bernard Thienpont, Thierry Voet and 4 more

Abstract read
In one paragraph

Article in Cancer discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ilana Struys *Department of Oncology, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0002-7490-7487
Carolina Velázquez *Department of Oncology, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0003-2477-8338
Joske Ubels *Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0002-1057-5225
Charlotte L LeJeuneDepartment of Oncology, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8508-6995
Markus J van RoosmalenPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0003-3329-1185
Axel K M Rosendahl HuberPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0003-4001-5605
Anais J C N van LeeuwenPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0001-7199-707X
Wouter BossuytDepartment of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0003-0067-2272
Bernard ThienpontDepartment of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8772-6845
Thierry VoetDepartment of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0003-1204-9963
Kristel Van CalsterenDepartment of Obstetrics and Gynaecology, University Hospitals Leuven, UZ Leuven, Leuven, Belgium.ORCID 0000-0002-2438-6783
Liesbeth Lenaerts *Department of Oncology, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0003-3565-2319
Ruben van Boxtel *Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0003-1285-2836
Frédéric Amant *Department of Oncology, University of Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0002-5452-4905

Funding

European Commission (EC) 893131Fonds Wetenschappelijk Onderzoek (FWO) 11K6822NHORIZON EUROPE European Research Council (ERC) 864499Kom op tegen Kanker (Fight Cancer)KU Leuven (Katholieke Universiteit Leuven) C14/21/113New York Stem Cell Foundation (NYSCF)Rijksdienst voor Ondernemend Nederland (RVO) NGFOP2201Stichting Tegen Kanker (Fondation Contre le Cancer) FAF-F/2018/1264
6 · The paper itself

Abstract

significanceThis study demonstrates that environmental mutagenic exposure during pregnancy can increase somatic mutation accumulation in the fetus. Given that detrimental early life exposures can adversely affect health outcomes later in life, our study highlights the need for further research into the impact of environmentally induced genomic insults during the perinatal period. See related commentary by Furudate and Takahashi, p. 870.

Indexed as

Antineoplastic AgentsHematopoietic Stem CellsMutationPrenatal Exposure Delayed EffectsFemaleHumansInfant, NewbornPregnancyAntineoplastic Agents

Identifiers

PMID39852764
PMCPMC12046327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.